YOLFTbeta
Coreline Soft, Co., Ltd.

Coreline Soft, Co., Ltd.

384470 · KQ · Healthcare / Diagnostics & Research

2,130.00KRW+60.00 (+2.90%)

Price History

Full chart

Market Stats

Previous Close2,070.00
Open2,060.00
Day Range1,999.00 – 2,130.00
52-Week Range1,820.00 – 4,735.00
Volume60.99K
Market Cap47.20B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.55
50-Day Avg2,622.80
200-Day Avg3,300.23

About

Coreline Soft Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases. It offers AVIEW Metric-Lung, a quantitative image biomarker software of COPD using chest CT images; AVIEW Modeler, a three-dimensional (3D) modeling software for 3D printing; and AVIEW Research, a software for medical research data management. The company was founded in 2012 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Jinkook Kim
  • Employees102
  • HeadquartersSung-Myung B/D 5F, Seoul, South Korea, 03991, Korea
  • Websitehttps://www.corelinesoft.com

Leadership

  • Mr. Jinkook KimChief Executive Officer · b. 1973
  • Wooseok Paul JongChief Financial Officer
  • Jaeyoun YiChief Technology Officer
  • Sanghyun PaikCMO
  • Joonmin ParkCPO

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.16B4.09B4.10B3.93B4.28B
Growth (%)-+89.34%+0.23%-4.18%+9.02%
Cost of Revenue-492.79M503.88M362.52M-
Gross Profit2.16B3.60B3.60B3.57B4.28B
Gross Margin100.00%87.95%87.71%90.77%100.00%
Operating Expense9.53B13.76B15.25B17.35B17.71B
Operating Income-7.37B-10.16B-11.66B-13.78B-13.43B
Operating Margin-341.00%-248.43%-284.25%-350.69%-313.41%
EBITDA--9.38B-13.19B-12.23B-11.60B
EBITDA Margin--229.23%-321.62%-311.17%-270.71%
Net Income-7.45B-10.21B-14.08B-14.14B-14.50B
Net Income Margin-344.80%-249.63%-343.43%-359.82%-338.41%
R&D1.92B2.09B1.98B2.69B2.05B
R&D as % of Total Revenue88.98%51.01%48.33%68.38%47.87%
Interest Expense95.49M75.29M162.95M1.41B2.08B
Interest Expense % of Total Revenue4.42%1.84%3.97%35.92%48.51%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.76B5.60B15.86B24.66B40.79B
Total Liabilities2.97B3.43B4.15B21.00B22.62B
Total Equity11.79B2.17B11.71B3.66B18.17B
Cash12.01B2.47B1.61B1.80B1.86B
Net Debt---9.07B10.96B

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.18B-8.78B-10.28B-10.82B-11.61B
Investing Cash Flow--241.61M-3.67B-6.93B-
Financing Cash Flow--661.42M13.08B17.85B-
Capital Expenditure357.60M227.06M173.08M491.53M3.40B
Free Cash Flow-7.54B-9.01B-10.46B-11.31B-15.01B
FCF to OCF104.98%102.59%101.68%104.54%129.24%

Earnings

Report DateSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------
EPS Actual-445.49-204.53-228.33-225.25-266.37-320.53-288.12-251.72-198.93-180.84-175.31-199.80
Surprise------------
Timing------------

Key Statistics & Ratios

Market Cap47.20B
Enterprise Value39.98B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.10
Price / Book3.61
Revenue (TTM)5.19B
Gross Profit (TTM)5.19B
EBITDA-11.22B
Profit Margin-267.70%
Operating Margin-149.40%
Return on Equity-73.94%
Return on Assets-19.73%
Shares Outstanding17.95M
Shares Float14.35M
Beta0.55
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%